N-(5-methylpyrazin-2-yl)-3-[(phenylmethyl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide → 3-Hydroxy-N-(5-methylpyrazin-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide
Reaction equation
[CH3:1][C:2]1[N:3]=[CH:4][C:5]([NH:8][C:9](=[O:30])[C:10]2[CH:15]=[C:14]([O:16][C@H:17]3[CH2:21][CH2:20][O:19][CH2:18]3)[CH:13]=[C:12]([O:22]CC3C=CC=CC=3)[CH:11]=2)=[N:6][CH:7]=1>[Pd].C(O)C.C1COCC1>[OH:22][C:12]1[CH:11]=[C:10]([CH:15]=[C:14]([O:16][C@H:17]2[CH2:21][CH2:20][O:19][CH2:18]2)[CH:13]=1)[C:9]([NH:8][C:5]1[CH:4]=[N:3][C:2]([CH3:1])=[CH:7][N:6]=1)=[O:30]Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
10% Palladium on charcoal (500 mg) was added to a solution of N-(5-methylpyrazin-2-yl)-3-[(phenylmethyl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide (5.0 g, 12.34 mmol) in ethanol (50 mL) and THF (100 mL) and the mixture stirred under an atmosphere of hydrogen at RT for 16 hours. The mixture was filtered through Celite®, the solvents evaporated in vacuo to a residue which was crystallised from ethyl acetate to give the desired material (3.6 g). 1H NMR δ (d6-DMSO): 2.0 (m, 1H), 2.25 (m, 1H), 2.5 (s, 3H), 3.75-3.95 (m, 4H), 5.1 (m, 1H), 6.5 (d, 1H), 7.0 (d, 1H), 7.05 (d, 1H), 8.35 (s, 1H), 9.25 (s, 1H), 9.75 (s, 1H), 10.8 (s, 1H); m/z 316 (M+H)+.
Workup
- filtrationThe mixture was filtered through Celite®
- customthe solvents evaporated in vacuo to a residue which
- customwas crystallised from ethyl acetate
Sources & evidence
- ORD record
- ord-0c8c3f75c0864b4f8d56fa702b9d586f
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07943607B2
Reaction notes
Loading…